CoH's specialty is discovering new molecules and their mechanisms of action in the m6A mRNA space. Full stop. But they are superb at doing that. They run rings around RAC.
RAC's specialties are resurrecting old chemotherapy molecules, developing new formulations of old drugs, developing companion diagnostic tests, conducting preclinical trials (using contractors), conducting Phase 2 trials (using CROs).
Neither CoH nor RAC are good at Phase 3 trials or commercialisation. And they both know it.
- Forums
- ASX - By Stock
- IGF2BP2 - Jianjun Chen's new mRNA target
CoH's specialty is discovering new molecules and their...
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.82 |
Change
-0.005(0.27%) |
Mkt cap ! $309.9M |
Open | High | Low | Value | Volume |
$1.83 | $1.86 | $1.79 | $157.7K | 86.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5623 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.82 | 9999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5623 | 1.790 |
1 | 544 | 1.785 |
2 | 1144 | 1.780 |
2 | 16544 | 1.775 |
2 | 1936 | 1.770 |
Price($) | Vol. | No. |
---|---|---|
1.820 | 9999 | 1 |
1.830 | 544 | 1 |
1.840 | 2044 | 2 |
1.845 | 544 | 1 |
1.850 | 544 | 1 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online